
Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy. In …

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …

Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …

Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …

Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …

The boss of a French firm at the centre of a global health scare over faulty breast implants has been …
A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …